Laboratory supply chain management is often inefficient and time consuming. Manual inventory tracking increases labor time and errors. Unknown inventory status results in shortages of critical items or overstocks and waste. Shortages of inventory may impact timely patient care.
The Radio Frequency Identification (RFID) technology behind AlinIQ IMS automates inventory receiving and tracking without the need for direct line-of-sight. It provides inventory status in real-time, minimizes patient care disruptions due to out-of-stock or expired inventory, and achieves cost savings by reducing hidden losses and operating expenses.
AlinIQ IMS is an open system, allowing you to incorporate and manage non-Abbott products by generating RFID tags for non-Abbott reagents.
AlinIQ IMS helps you maintain compliance with complete reagent traceability records, including the date received and the lot number.
AlinIQ IMS allows you to manage inventory from different locations; perfect for your brand hospital laboratories and satellite offices.
AlinIQ, the suite of Digital Health Solutions from Abbott, helps you uncover intelligent insights from your laboratory data and discover greater operational productivity with existing resources.
Find the latest information in laboratory science, therapeutic areas and Abbott innovation.
Receive exclusive benefits and resources when you register to access to the customer portal.
Abbott's Representatives are ready to offer support, gather feedback, and answer any questions.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
